International Biotechnology (LON:IBT) Stock Crosses Above 50-Day Moving Average – Here’s What Happened

International Biotechnology (LON:IBT) shares passed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of GBX 1,072.15 and traded as high as GBX 1,090. International Biotechnology shares last traded at GBX 1,080, with a volume of 29,593 shares changing hands.

International Biotechnology Stock Performance

The stock has a market cap of £340.80 million, a price-to-earnings ratio of 4.45 and a beta of 0.47. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.32 and a current ratio of 0.11. The company’s 50 day simple moving average is GBX 1,072.15 and its 200 day simple moving average is GBX 1,012.37.

International Biotechnology (LON:IBT) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported GBX (10.22) earnings per share (EPS) for the quarter. The company had revenue of GBX 46 million during the quarter. International Biotechnology had a net margin of 95.99% and a return on equity of 44.12%. On average, equities research analysts anticipate that International Biotechnology will post 0.94 earnings per share for the current year.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.